EMCURE PHARMACEUTICALS IPO Review - Issue Date, Price, GMP, Subscription, Allotment, Lot Size, and Details

IPO Details IPO GMP IPO Subscription Reviews About Company IPO Timeline KPI Financial Information Peer Comparison Allotment

EMCURE PHARMACEUTICALS Limited Financial Information (Restated Consolidated)

Amount in (₹ in Millions)

Period Ended	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Reserve of Surplus	27,711.31	23,202.74	18,066.96
Total Assets	78,061.63	66,725.31	60,634.69
Total Borrowings	20,919.35	22,024.21	21,021.90
Fixed Assets	19,485.73	16,046.34	14,702.77
Cash	1,690.00	2,423.42	1,628.49
Net Borrowing	1,9229.35	19,600.79	19,393.41
Revenue	67,152.41	60,317.16	59,188.60
EBITDA	12,767.82	12,209.41	13,933.81
PAT	5,275.75	5,618.45	7,025.56
EPS	27.54	29.42	36.63

Note 1:- ROCE & ROE calculation in KPI is based on 31st DMar, 2024 Data, given in RHP.
Note 2:- Pre EPS and Post EPS in KPI is based on 31st Mar, 2024 Data, given in RHP.
Note 3:- RoNW calculation in KPI is based on 31st Mar, 2024 Data, given in RHP.
Note 4:- Price to Book Value calculation in KPI is based on Cap Price after completion of Offer Price.

Services

Equity Trading with CA Abhay

Option Trading with CA Abhay

Stock Market Masterclass

Equity Investment with CA Abhay

FNO Stocks with CA Abhay